Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis.
暂无分享,去创建一个
D McLerran | E S Fisher | M. Barry | E. Fisher | N. Roos | D. Malenka | J. Wennberg | D. McLerran | R. Bruskewitz | F. Whaley | M J Barry | J E Wennberg | D J Malenka | F S Whaley | N Roos | R Bruskewitz | F. S. Whaley | DALE F. Mclerran | David J. Malenka | Noralou P. Roos | J. Wennberg | E. S. Fisher | Michael J. Barry | Reginald C. Bruskewitz
[1] P. Kendall‐Taylor,et al. RISK FACTOR FOR MYOCARDIAL INFARCTION IN TRANSURETHRAL RESECTION OF PROSTATE? , 1989, The Lancet.
[2] C. Mackenzie,et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.
[3] N. Roos,et al. Use of claims data systems to evaluate health care outcomes. Mortality and reoperation following prostatectomy. , 1987, JAMA.
[4] J. Melby,et al. ENALAPRIL (MK-421) AND THE WHITE CELL COUNT AND HAEMATOCRIT , 1982, The Lancet.
[5] K McPherson,et al. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia. , 1989, The New England journal of medicine.
[6] R. P. Hastings,et al. SUGI supplemental library user's guide , 1986 .
[7] N. Roos,et al. A population-based study of prostatectomy: outcomes associated with differing surgical approaches. , 1987, The Journal of urology.
[8] Langeveld Mj. Letter: Fenestrated tracheostomy tubes. , 1973 .
[9] K E Stanley,et al. Prognostic factors for survival in patients with inoperable lung cancer. , 1980, Journal of the National Cancer Institute.